Elanco Animal Health (ELAN) Receivables - Net (2017 - 2026)

Elanco Animal Health (ELAN) has 10 years of Receivables - Net data on file, last reported at $1.1 billion in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Net rose 11.75% year-over-year to $1.1 billion; the trailing twelve-month figure through Mar 2026 stood at $1.1 billion (up 11.75% YoY), and the FY2025 full-year result was $873.0 million, up 8.45% from the prior year.
• Receivables - Net rose to $1.1 billion in Q1 2026, from $873.0 million in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $1.1 billion in Q1 2026 to a low of $797.0 million in Q4 2022.
• A 5-year average of $925.6 million and a median of $916.0 million in 2022 frame the typical range for Receivables - Net.
• Across the five-year window, Receivables - Net dropped 14.15% in 2022 and advanced 13.31% in 2023, its largest moves.
• Tracing ELAN's Receivables - Net over 5 years: stood at $797.0 million in 2022, then climbed by 5.65% to $842.0 million in 2023, then declined by 4.39% to $805.0 million in 2024, then rose by 8.45% to $873.0 million in 2025, then gained by 24.17% to $1.1 billion in 2026.
• Business Quant data shows ELAN's Receivables - Net at $1.1 billion in Q1 2026, $873.0 million in Q4 2025, and $894.0 million in Q3 2025.